Category: bromides-buliding-blocks

Watanabe, Hideyuki et al. published their patent in 2022 |CAS: 1805937-67-0

The Article related to antibody immunotherapy resistant cancer treatment, heteroaryl carboxamide preparation dgkzeta inhibitor anticancer, phenylpyrazolecarboxamide phenyloxodihydropyridinecarboxamide phenyloxazolecarboxamide preparation dgkzeta inhibitor anticancer and other aspects.Electric Literature of 1805937-67-0

On June 2, 2022, Watanabe, Hideyuki; Kamikubo, Takashi; Kamikawa, Akio; Washio, Takuya; Seki, Yohei; Okuyama, Keiichiro; Ikeda, Osamu; Tomiyama, Hiroshi; Iwai, Yoshinori; Nakamura, Akihiko; Miyasaka, Kozo published a patent.Electric Literature of 1805937-67-0 The title of the patent was Preparation of heteroaryl carboxamide compounds as DGKζ (DGKzeta) inhibitors and anticancer agents. And the patent contained the following:

Heteroaryl carboxamide compounds including N-phenyl-1H-pyrazole-3-carboxamides, N-phenyl-2-oxo-1,2-dihydropyridine-3-carboxamides, and N-phenyloxazole-4-carboxamides represented by formula I [A = Q1, Q2, Q3, or Q4; B = Q5, Q6, Q7, or Q8; when R1 a = halo-C1-6 alkyl, B = Q5; R1a = pyridazinyl or halo-C1-6 alkyl; R1b = H or C1-6 alkyl; R2 = C3-5 cycloalkyl, C1-6 alkyloxy, halo-C1-6 alkyl, halo, or Ph; R3 = each (un)substituted Ph, C3-8 cycloalkyl, or pyridyl, or 5- or 6-membered partially unsaturated heterocyclyl containing 1-4 heteroatoms selected from O, S, and N atoms; R4 = H or F; R6 = -L2-(CH2)2NRaRb, or piperidinyl; L1 = a singe bond, O, or NH; L2 = a single bond, O, or CH2; X = CH2 or NMe; Y = CH or N; Ra = H or Me; Rb = H, Me, Et, cyclopropyl, or (CH2)2OMe; m = 1, 2, or 3] or salts thereof are prepared The compounds I or salts thereof have a DGKζ (DGKzeta) inhibiting activity and are useful as active ingredients for pharmaceutical compositions for treating cancer associated with the activation of an immunocyte or cancer having resistance to an anti-PD-1 antibody/anti-PD-L1 antibody therapy. Thus, [[(2R)-4-[6-amino-3-(2-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-methylpiperazin-2-yl]methyl](methyl)carbamic acid tert-Bu ester was condensed with 1-(pyridazin-4-yl)-1H-pyrazole-3-carboxylic acid using HATU in the presence of diisopropylethylamine in DMF at 50° for 12 h to give [[(2R)-4-[3-(2-fluorophenoxy)-6-[[[1-(pyridazin-4-yl)-1H-pyrazol-3-yl]carbonyl]amino]-2-(trifluoromethyl)phenyl]-1-methylpiperazin-2-yl]methyl](methyl)carbamic acid tert-Bu ester which was treated with CF3CO2H in CH2Cl2 at room temperature for 4 h followed by purification using silica gel chromatog. (CHCl3/MeOH/aqueous ammonia solution) to give N-[4-(2-fluorophenoxy)-2-[(3S)-4-methyl-3-[(methylamino)methyl]piperazin-1-yl]-3-(trifluoromethyl)phenyl]-1-(pyridazin-4-yl)-1H-pyrazole-3-carboxamide (II). II, II monobutanedioate, and compound (III) showed IC50 of 10, 3.2, 0.42 nM, resp., against human recombinant DGKζ (DGKzeta). The experimental process involved the reaction of 2-Bromo-4-fluoro-1-nitro-3-(trifluoromethyl)benzene(cas: 1805937-67-0).Electric Literature of 1805937-67-0

The Article related to antibody immunotherapy resistant cancer treatment, heteroaryl carboxamide preparation dgkzeta inhibitor anticancer, phenylpyrazolecarboxamide phenyloxodihydropyridinecarboxamide phenyloxazolecarboxamide preparation dgkzeta inhibitor anticancer and other aspects.Electric Literature of 1805937-67-0

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Ko, Soo Sung et al. published their patent in 2014 |CAS: 1261475-16-4

The Article related to carbazolecarboxamide preparation bruton tyrosine kinase btk kinase inhibitor, phenylcarbazolecarboxamide preparation kinase inhibitor, autoimmune disease chronic inflammatory disease treatment prevention phenylcarbazolecarboxamide preparation and other aspects.Recommanded Product: 1-Bromo-3-isocyanato-2-methyl-benzene

On December 31, 2014, Ko, Soo Sung; Batt, Douglas A.; Bertrand, Myra Beaudoin; Delucca, George V.; Langevine, Charles M.; Liu, Qingjie; Srivastava, Anurag S.; Watterson, Scott Hunter published a patent.Recommanded Product: 1-Bromo-3-isocyanato-2-methyl-benzene The title of the patent was Preparation of 4-phenylcarbazole-1-carboxamide compounds useful as Bruton’s tyrosine kinase (Btk) inhibitors. And the patent contained the following:

There are disclosed carbazolecarboxamide compounds of formula [I; Q = Q1, Q2, Q3, or Q4; R1 = C(CH3)2OH, NHC(O)C(CH3)3, N(CH3)2, or CH2Rd; R2 = Cl or CH3; R3 = H, F, or CH3; Ra = H or CH3; Rb = H, F, Cl, or OCH3; Rc = H or F; Rd = OH, OCH3, NHC(O)CH3, or pyrrolidin-1-yl] or salts thereof. These compounds are inhibitors of kinases, in particular Bruton’s tyrosine kinase (Btk) and are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and chronic inflammatory diseases. Thus, 4-bromo-7-(2-hydroxypropan-2-yl)-9H-carbazole-1-carboxamide was coupled with 5-chloro-2-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-pyrido[1,2-c]pyrimidine-1,3(2H)-dione in the presence of Pd2(dppf).CH2Cl2adduct and Cs2CO3 in THF under argon at 45° for 3.5 h to give 39% 4-[3-(5-chloro-1,3-dioxo-1H-pyrido[1,2-c]pyrimidin-2(3H)-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-9H-carbazole-1-carboxamide as a mixture of 4 diastereomers which was separated by chiral super-critical fluid chromatog. to give 4-[3-(R)-(5-Chloro-1,3-dioxo-1H-pyrido[1,2-c]pyrimidin-2(3H)-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-9H-carbazole-1-carboxamide (II) and 4-[3-(S)-(5-chloro-1,3-dioxo-1H-pyrido[1,2-c]pyrimidin-2(3H)-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-9H-carbazole-1-carboxamide (III). III showed IC50 of 0.41 and 1,000 nM against human recombinant Bruton’s tyrosine kinase (Btk) and Jak2 tyrosine kinase, resp. The experimental process involved the reaction of 1-Bromo-3-isocyanato-2-methyl-benzene(cas: 1261475-16-4).Recommanded Product: 1-Bromo-3-isocyanato-2-methyl-benzene

The Article related to carbazolecarboxamide preparation bruton tyrosine kinase btk kinase inhibitor, phenylcarbazolecarboxamide preparation kinase inhibitor, autoimmune disease chronic inflammatory disease treatment prevention phenylcarbazolecarboxamide preparation and other aspects.Recommanded Product: 1-Bromo-3-isocyanato-2-methyl-benzene

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Sidhu, Jagpreet Singh et al. published their research in European Journal of Inorganic Chemistry in 2020 |CAS: 574-98-1

The Article related to nickel naphthalimide heterodipodal schiff base preparation degrade pesticide, crystal mol structure naphthalimide heterodipodal schiff base, phosphorothioate organophosphate hydrolysis catalyst naphthalimide heterodipodal schiff base nickel and other aspects.Formula: C10H8BrNO2

On August 5, 2020, Sidhu, Jagpreet Singh; Raj, Pushap; Pandiyan, Thangarasu; Singh, Narinder published an article.Formula: C10H8BrNO2 The title of the article was Synthesis of Nickel(II) Complexes of Novel Naphthalimide Based Heterodipodal Schiff Base Ligands, Structure, Characterization and Application for Degradation of Pesticides. And the article contained the following:

To degrade the highly toxic pesticide into less harmful components, authors have synthesized four nickel complexes of naphthalimide based organic ligands. These complexes catalyze the hydrolysis of phosphorothioate bonds of organophosphates in an aqueous medium. The metal complexes {[Ni(L1)2]-[Ni(L4)2]} were synthesized by the electrochem. method and characterized using single-crystal x-ray crystallog. and mass spectrometry. Anal. techniques revealed that complexes are mononuclear and possess octahedral geometry. The rate of degradation of chlorpyriphos and parathion Me was evaluated using 31P NMR and LC-MS chromatogram. The byproduct of chlorpyriphos upon catalytic degradation with complex was confirmed from mass spectrometry. It was found that chlorpyriphos degrade into 3,5,6-trichloropyridin-2-ol after 50 min of incubation with catalyst. However, parathion Me took only 20 min to hydrolyze into its byproduct. Moreover, the inhibition assay of acetylcholinesterase was performed for pesticides in the presence of metal complex and the interesting outcome was recorded. The experimental process involved the reaction of 2-(2-Bromoethyl)isoindoline-1,3-dione(cas: 574-98-1).Formula: C10H8BrNO2

The Article related to nickel naphthalimide heterodipodal schiff base preparation degrade pesticide, crystal mol structure naphthalimide heterodipodal schiff base, phosphorothioate organophosphate hydrolysis catalyst naphthalimide heterodipodal schiff base nickel and other aspects.Formula: C10H8BrNO2

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Meng, Depei et al. published their research in Chemistry – A European Journal in 2022 |CAS: 2567-29-5

The Article related to trifluoromethyl benzothioate preparation aryne halogenation trifluoromethylthiolation, halo trifluoromethylthio arene preparation, s-(trifluoromethyl)benzothioate, aryne, multifunctionalization, potassium fluoride, trifluoromethylthiolation and other aspects.Electric Literature of 2567-29-5

On March 1, 2022, Meng, Depei; Lyu, Yichong; Ni, Chuanfa; Zhou, Min; Li, Yang; Hu, Jinbo published an article.Electric Literature of 2567-29-5 The title of the article was S-(Trifluoromethyl)Benzothioate (TFBT): A KF-Based Reagent for Nucleophilic Trifluoromethylthiolation. And the article contained the following:

S-(Trifluoromethyl)benzothioate (TFBT) was developed as an inexpensive, bench-stable and user-friendly trifluoromethylthiolation reagent which was easily synthesized by using KF as the only fluorine source. By using TFBT, trifluoromethylthiolates with various counterions was readily obtained. The synthetic application of TFBT was demonstrated by trifluoromethylthiolation-halogenation of arynes, bis(trifluoromethylthiolation)-halogenation of 1,2-benzdiynes, nucleophilic substitution of alkyl halides, deoxytrifluoromethylthiolation of alcs., and cross-coupling with aryl and vinyl boronic acids. The experimental process involved the reaction of 4-(Bromomethyl)-1,1′-biphenyl(cas: 2567-29-5).Electric Literature of 2567-29-5

The Article related to trifluoromethyl benzothioate preparation aryne halogenation trifluoromethylthiolation, halo trifluoromethylthio arene preparation, s-(trifluoromethyl)benzothioate, aryne, multifunctionalization, potassium fluoride, trifluoromethylthiolation and other aspects.Electric Literature of 2567-29-5

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Zhou, Peng team published research in Journal of Environmental Science and Health in 2021 | 5445-17-0

5445-17-0, Methyl 2-bromopropionate, also known as Methyl 2-bromopropionate, is a useful research compound. Its molecular formula is C4H7BrO2 and its molecular weight is 167 g/mol. The purity is usually 95%.
Methyl 2-bromopropionate is used in the synthesis of poly(ADP-Ribose)polymerase inhibitors derived from benzoxazin-3-one. Also used in the synthesis of 5-HT2C antagonists affecting serotonin levels.
Methyl 2-bromopropanoate is a chemical compound that can be synthesized in an asymmetric manner. The reaction of methyl 2-bromopropanoate with hydrochloric acid gives the corresponding carboxylic acid, methyl propanoate, and hydrogen bromide in a 1:1 ratio. It has been shown that methyl 2-bromopropanoate is a potential catalyst for the reduction of chloride to chloride ion via the borohydride reduction method. Methyl 2-bromopropanoate has also been used as a model system for studying halides and copper complexes. Magnetic resonance spectroscopy studies have revealed that this chemical compound has a high redox potential and kinetic properties., Recommanded Product: Methyl 2-bromopropanoate

A variety of minor organobromine compounds are found in nature, but none are biosynthesized or required by mammals. 5445-17-0, formula is C4H7BrO2, Name is Methyl 2-bromopropanoate. Organobromine compounds have fallen under increased scrutiny for their environmental impact., Recommanded Product: Methyl 2-bromopropanoate.

Zhou, Peng research published 《 Polyacrylic acid-b-polyptyrene covered Ni/Fe nanoparticles to remove 1,1,1-trichloroethane in water》, the research content is summarized as follows. A new material, polyacrylic acid-b-polyptyrene (PAA-b-PS) covered Ni/Fe nanoparticles (PAA-b-PS-nZVI-Ni), was developed and evaluated for the selective dechlorination of 1,1,1-trichloroethane (1,1,1-TCA) in the presence of potential interferents. The average size of the PAA-b-PS coated Fe/Ni bimetallic nanoparticles was approx. 50 nm, which resulted from agglomeration prevention by PAA-b-PS. The removal efficiency of 1,1,1-TCA by an optimal dose with a 1.0 g/L Fe/Ni (Ni/Fe = 2 wt%) and 0.5 g/L PAA-b-PS-coated concentration was higher (87.5%) than that of bare Fe/Ni (60%). The pseudo-first-order rate constant (Kobs) of 1,1,1-TCA removal by PAA-b-PS-nZVI-Ni was 0.0142 min-1 within 240 min. Comparatively, the Kobs values of 1,1,1-TCA removal by other materials (Fe, pure bimetallic Fe/Ni, PAA-b-PS-Fe) were only 0.003, 0.0052 and 0.0103 min-1, resp. The 1,1,1-TCA removal efficacy by PAA-b-PS-nZVI-Ni showed no obvious gap regardless of pH or various common inorganic anions (NO3–, HCO3– and SO42-) at different concentrations However, humic acid (HA) had great influence on the degradation of 1,1,1-TCA. In conclusion, PAA-b-PS-covered Ni/Fe nanoparticles with its selectivity high effectiveness could be used as one remedial agent for the degradation of 1,1,1-TCA in water.

5445-17-0, Methyl 2-bromopropionate, also known as Methyl 2-bromopropionate, is a useful research compound. Its molecular formula is C4H7BrO2 and its molecular weight is 167 g/mol. The purity is usually 95%.
Methyl 2-bromopropionate is used in the synthesis of poly(ADP-Ribose)polymerase inhibitors derived from benzoxazin-3-one. Also used in the synthesis of 5-HT2C antagonists affecting serotonin levels.
Methyl 2-bromopropanoate is a chemical compound that can be synthesized in an asymmetric manner. The reaction of methyl 2-bromopropanoate with hydrochloric acid gives the corresponding carboxylic acid, methyl propanoate, and hydrogen bromide in a 1:1 ratio. It has been shown that methyl 2-bromopropanoate is a potential catalyst for the reduction of chloride to chloride ion via the borohydride reduction method. Methyl 2-bromopropanoate has also been used as a model system for studying halides and copper complexes. Magnetic resonance spectroscopy studies have revealed that this chemical compound has a high redox potential and kinetic properties., Recommanded Product: Methyl 2-bromopropanoate

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Zhou, Shuai team published research in Organic & Biomolecular Chemistry in 2022 | 402-49-3

402-49-3, 4-Trifluoromethylbenzyl bromide is a useful research compound. Its molecular formula is C8H6BrF3 and its molecular weight is 239.03 g/mol. The purity is usually 95%.
4-Trifluoromethylbenzyl bromide is a choline derivative that acts as an anticancer agent. It is structurally similar to the anticancer drug doxorubicin, which has been shown to be effective against breast cancer and leukemia. 4-Trifluoromethylbenzyl bromide interacts with cellular proteins, including choline kinase, and inhibits the mitochondrial pathway. This leads to cell death through apoptosis. The molecule also interacts with nucleotide bases such as thymine and cytosine in DNA, inhibiting transcription and replication. 4-Trifluoromethylbenzyl bromide binds strongly to the hydroxyl group of cholesterol by an electrophilic substitution mechanism to form a covalent bond with its hydroxy group. The molecule can also bind to chloride ions by an ionic bond., Safety of 1-(Bromomethyl)-4-(trifluoromethyl)benzene

Organic compounds having carbon bonded to bromine are called organic bromides. 402-49-3, formula is C8H6BrF3, Name is 1-(Bromomethyl)-4-(trifluoromethyl)benzene. Depending on the type of carbon to which the bromine is bonded, organic bromide could be alkyl, alkenyl, alkynyl, or aryl. Safety of 1-(Bromomethyl)-4-(trifluoromethyl)benzene.

Zhou, Shuai;Xu, Xiaojuan;Zhu, Xu;Zheng, Yu;Chen, Sufang;Xue, Mingqiang research published 《 A facile approach to C-functionalized β-ketoimine compounds via terminal alkylation of a tetralithiated intermediate》, the research content is summarized as follows. A series of C-functionalized β-ketoimine compounds at the terminal Me groups of the β-ketoimine precursor LphH2 (Lph = C6H4[NC(Me)=CHC(Me)O]2) were prepared This convenient transformation was realized via straightforward double alkylation on the terminal Cα of a novel bis-dianionic β-ketoiminate lithium complex [Lph’Li4(THF)4]2 (Lph’ = C6H4[NC(Me)CHC(O)CH2]2) followed by hydrolysis.

402-49-3, 4-Trifluoromethylbenzyl bromide is a useful research compound. Its molecular formula is C8H6BrF3 and its molecular weight is 239.03 g/mol. The purity is usually 95%.
4-Trifluoromethylbenzyl bromide is a choline derivative that acts as an anticancer agent. It is structurally similar to the anticancer drug doxorubicin, which has been shown to be effective against breast cancer and leukemia. 4-Trifluoromethylbenzyl bromide interacts with cellular proteins, including choline kinase, and inhibits the mitochondrial pathway. This leads to cell death through apoptosis. The molecule also interacts with nucleotide bases such as thymine and cytosine in DNA, inhibiting transcription and replication. 4-Trifluoromethylbenzyl bromide binds strongly to the hydroxyl group of cholesterol by an electrophilic substitution mechanism to form a covalent bond with its hydroxy group. The molecule can also bind to chloride ions by an ionic bond., Safety of 1-(Bromomethyl)-4-(trifluoromethyl)benzene

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Zhou, Wenjuan team published research in European Journal of Medicinal Chemistry in 2021 | 585-76-2

Electric Literature of 585-76-2, 3-bromobenzoic acid is a bromobenzoic acid carrying a single bromo subsituent at the 3-position.
3-Bromobenzoic acid, also known as 3-Bromobenzoic acid, is a useful research compound. Its molecular formula is C7H5BrO2 and its molecular weight is 201.02 g/mol. The purity is usually 95%.
3-bromobenzoic acid is used as a reagent in the synthesis of deoxypodophyllotoxin derivatives with insecticidal activity. Also used as a reagent in the synthesis of thiazole derivatives with antibacterial activity.
3-bromobenzoic acid is a molecule that is classified as a Group P2. It has an electronegativity of 1.3 and an acidity of 0.8, which are both in the middle range of values for this group. 3-Bromobenzoic acid is soluble in water and is soluble in ethanol, acetone, and ether. The chemical structure of 3-bromobenzoic acid can be determined by its monoclonal antibody binding sites, electrochemical impedance spectroscopy data, and Langmuir adsorption isotherm data. 3-Bromobenzoic acid reacts with hydrochloric acid to form benzoate and HCl gas. Chronic exposure to 3-bromobenzoic acid has been shown to cause glutamate dehydrogenase inhibition, leading to an accumulation of p-hydroxybenzoic acid in the body. , 585-76-2.

Organic compounds having carbon bonded to bromine are called organic bromides. 585-76-2, formula is C7H5BrO2, Name is 3-Bromobenzoic acid. Depending on the type of carbon to which the bromine is bonded, organic bromide could be alkyl, alkenyl, alkynyl, or aryl. Electric Literature of 585-76-2.

Zhou, Wenjuan;Xu, Chenhao;Dong, Guanjun;Qiao, Hui;Yang, Jing;Liu, Hongmin;Ding, Lina;Sun, Kai;Zhao, Wen research published 《 Development of phenyltriazole thiol-based derivatives as highly potent inhibitors of DCN1-UBC12 interaction》, the research content is summarized as follows. Defective in cullin neddylation 1(DCN1) is a co-E3 ligase that is important for cullin neddylation. Dysregulation of DCN1 highly correlates with the development of various cancers. Herein, from the initial high-throughput screening, a novel hit compound 5a containing a phenyltriazole thiol core (IC50 value of 0.95μM for DCN1-UBC12 interaction) was discovered. Further structure-based optimization leads to the development of SK-464 (IC50 value of 26 nM). We found that SK-464 not only directly bound to DCN1 in vitro, but also engaged cellular DCN1, suppressed the neddylation of cullin3, and hindered the migration and invasion of two DCN1-overexpressed squamous carcinoma cell lines (KYSE70 and H2170). These findings indicate that SK-464 may be a novel lead compound targeting DCN1-UBC12 interaction.

Electric Literature of 585-76-2, 3-bromobenzoic acid is a bromobenzoic acid carrying a single bromo subsituent at the 3-position.
3-Bromobenzoic acid, also known as 3-Bromobenzoic acid, is a useful research compound. Its molecular formula is C7H5BrO2 and its molecular weight is 201.02 g/mol. The purity is usually 95%.
3-bromobenzoic acid is used as a reagent in the synthesis of deoxypodophyllotoxin derivatives with insecticidal activity. Also used as a reagent in the synthesis of thiazole derivatives with antibacterial activity.
3-bromobenzoic acid is a molecule that is classified as a Group P2. It has an electronegativity of 1.3 and an acidity of 0.8, which are both in the middle range of values for this group. 3-Bromobenzoic acid is soluble in water and is soluble in ethanol, acetone, and ether. The chemical structure of 3-bromobenzoic acid can be determined by its monoclonal antibody binding sites, electrochemical impedance spectroscopy data, and Langmuir adsorption isotherm data. 3-Bromobenzoic acid reacts with hydrochloric acid to form benzoate and HCl gas. Chronic exposure to 3-bromobenzoic acid has been shown to cause glutamate dehydrogenase inhibition, leading to an accumulation of p-hydroxybenzoic acid in the body. , 585-76-2.

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Zhou, Xiao-Yu team published research in Synthesis in 2021 | 585-76-2

585-76-2, 3-bromobenzoic acid is a bromobenzoic acid carrying a single bromo subsituent at the 3-position.
3-Bromobenzoic acid, also known as 3-Bromobenzoic acid, is a useful research compound. Its molecular formula is C7H5BrO2 and its molecular weight is 201.02 g/mol. The purity is usually 95%.
3-bromobenzoic acid is used as a reagent in the synthesis of deoxypodophyllotoxin derivatives with insecticidal activity. Also used as a reagent in the synthesis of thiazole derivatives with antibacterial activity.
3-bromobenzoic acid is a molecule that is classified as a Group P2. It has an electronegativity of 1.3 and an acidity of 0.8, which are both in the middle range of values for this group. 3-Bromobenzoic acid is soluble in water and is soluble in ethanol, acetone, and ether. The chemical structure of 3-bromobenzoic acid can be determined by its monoclonal antibody binding sites, electrochemical impedance spectroscopy data, and Langmuir adsorption isotherm data. 3-Bromobenzoic acid reacts with hydrochloric acid to form benzoate and HCl gas. Chronic exposure to 3-bromobenzoic acid has been shown to cause glutamate dehydrogenase inhibition, leading to an accumulation of p-hydroxybenzoic acid in the body. , SDS of cas: 585-76-2

Organic bromides such as alkyl bromides are used as fumigants in agriculture to control insects. 585-76-2, formula is C7H5BrO2, Name is 3-Bromobenzoic acid. Ethylene bromide is one of the commercially important organic bromides which are the component of leaded gasoline. SDS of cas: 585-76-2.

Zhou, Xiao-Yu;Chen, Xia research published 《 Oxidative C-H Acyloxylation of Acetone with Carboxylic Acids under Iodine Catalysis》, the research content is summarized as follows. Iodine-catalyzed oxidative C(sp3)-H acyloxylation of acetone with carboxylic acids was developed. The method employed iodide as catalyst and sodium chlorite as oxidant. Substituted benzoic acids, naphthoic acids and heteroaromatic carboxylic acids could be used and 2-oxopropyl carboxylates ArC(O)OCH2C(O)CH3 [Ar = Ph, 4-BrC6H4, 2-furyl, etc.] were obtained with good to excellent yields.

585-76-2, 3-bromobenzoic acid is a bromobenzoic acid carrying a single bromo subsituent at the 3-position.
3-Bromobenzoic acid, also known as 3-Bromobenzoic acid, is a useful research compound. Its molecular formula is C7H5BrO2 and its molecular weight is 201.02 g/mol. The purity is usually 95%.
3-bromobenzoic acid is used as a reagent in the synthesis of deoxypodophyllotoxin derivatives with insecticidal activity. Also used as a reagent in the synthesis of thiazole derivatives with antibacterial activity.
3-bromobenzoic acid is a molecule that is classified as a Group P2. It has an electronegativity of 1.3 and an acidity of 0.8, which are both in the middle range of values for this group. 3-Bromobenzoic acid is soluble in water and is soluble in ethanol, acetone, and ether. The chemical structure of 3-bromobenzoic acid can be determined by its monoclonal antibody binding sites, electrochemical impedance spectroscopy data, and Langmuir adsorption isotherm data. 3-Bromobenzoic acid reacts with hydrochloric acid to form benzoate and HCl gas. Chronic exposure to 3-bromobenzoic acid has been shown to cause glutamate dehydrogenase inhibition, leading to an accumulation of p-hydroxybenzoic acid in the body. , SDS of cas: 585-76-2

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Zhou, Yan team published research in Molecular Catalysis in 2022 | 90-59-5

Safety of 3,5-Dibromo-2-hydroxybenzaldehyde, 3,5-Dibromosalicylaldehyde reacts with alkyl cyanoacetates in the presence of ammonium acetate to yield 4H- chromenes.

3,5-Dibromosalicylaldehyde, also known as 3,5-Dibromosalicylaldehyde, is a useful research compound. Its molecular formula is C7H4Br2O2 and its molecular weight is 279.91 g/mol. The purity is usually 95%.

3,5-Dibromosalicylaldehyde reacts with alkyl cyanoacetates in the presence of ammonium acetate to yield 4H- chromenes. 3,5-Dibromosalicylaldehyde can be used in the synthesis of Schiff base and can be used as reactant for synthesis of Schiff base ligands which forms mononuclear complexes with copper(II), nickel(II), zinc(II) and cobalt(II).

3,5-Dibromosalicylaldehyde is a copper complex that has been synthesized from 3,5-dibromosalicylaldehyde and copper chloride. FTIR spectroscopy revealed that the coordination geometry of the copper complex is octahedral with two nitrogen atoms in the equatorial plane. The presence of hydrogen bonding interactions was confirmed by homologous protein adsorption experiments. This chemical structure was determined using X-ray crystallography and fluorescence probe experiments. The copper complex showed high affinity for malonic acid, which is an ester hydrochloride. The molecular mechanism of this interaction is based on adsorption, which occurs through hydrogen bonding interactions and hydrophobic interactions. Structural analysis revealed that the polymeric matrix consists of a three-dimensional network of crosslinked chains, while FTIR analysis indicated a possible disulfide bond between two cysteine residues., 90-59-5.

Organobromine compounds, also called organobromides, are organic compounds that contain carbon bonded to bromine. 90-59-5, formula is C7H4Br2O2, The most pervasive is the naturally produced bromomethane. Safety of 3,5-Dibromo-2-hydroxybenzaldehyde

Zhou, Yan;Zhou, Zebiao;Liu, Siqi;Cai, Mingzhong research published 《 Recyclable palladium-catalyzed cyclocarbonylation between benzyl chlorides and salicylic aldehydes towards coumarins》, the research content is summarized as follows. A novel and practical route to coumarin derivatives was developed via the heterogeneous Pd-catalyzed carbonylative reaction and subsequent intramol. condensation process starting from com. easily available benzyl chlorides and salicylic aldehydes. Reactions were performed in the existence of 2 mol% of an SBA-15-immobilized bidentate phosphine palladium complex [SBA-15-P,P-PdCl2] in dioxane at 110°C with Et3N as base under 10 bar of CO to afford a wide range of coumarin derivatives mostly with good to high yields. Importantly, this new heterogenized palladium complex was easy to recover via filtration of the reaction mixture, and was recyclable up to 8 times without apparent drop in its catalytic performance.

Safety of 3,5-Dibromo-2-hydroxybenzaldehyde, 3,5-Dibromosalicylaldehyde reacts with alkyl cyanoacetates in the presence of ammonium acetate to yield 4H- chromenes.

3,5-Dibromosalicylaldehyde, also known as 3,5-Dibromosalicylaldehyde, is a useful research compound. Its molecular formula is C7H4Br2O2 and its molecular weight is 279.91 g/mol. The purity is usually 95%.

3,5-Dibromosalicylaldehyde reacts with alkyl cyanoacetates in the presence of ammonium acetate to yield 4H- chromenes. 3,5-Dibromosalicylaldehyde can be used in the synthesis of Schiff base and can be used as reactant for synthesis of Schiff base ligands which forms mononuclear complexes with copper(II), nickel(II), zinc(II) and cobalt(II).

3,5-Dibromosalicylaldehyde is a copper complex that has been synthesized from 3,5-dibromosalicylaldehyde and copper chloride. FTIR spectroscopy revealed that the coordination geometry of the copper complex is octahedral with two nitrogen atoms in the equatorial plane. The presence of hydrogen bonding interactions was confirmed by homologous protein adsorption experiments. This chemical structure was determined using X-ray crystallography and fluorescence probe experiments. The copper complex showed high affinity for malonic acid, which is an ester hydrochloride. The molecular mechanism of this interaction is based on adsorption, which occurs through hydrogen bonding interactions and hydrophobic interactions. Structural analysis revealed that the polymeric matrix consists of a three-dimensional network of crosslinked chains, while FTIR analysis indicated a possible disulfide bond between two cysteine residues., 90-59-5.

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Zhou, Yu team published research in Journal of Medicinal Chemistry in 2021 | 823-78-9

823-78-9, 3-Bromobenzyl bromide undergoes reduction with diethylzinc in the presence of Pd(PPh3)4 to yield corresponding hydrocarbon.

3-Bromobenzyl bromide is a useful research compound. Its molecular formula is C7H6Br2 and its molecular weight is 249.93 g/mol. The purity is usually 95%.

3-Bromobenzyl bromide is a molecule that has been synthesized and shown to have anticancer activity. It inhibits the activity of cancer cells by binding to amines in these cells and preventing the formation of hydrogen bonds between these molecules. 3-Bromobenzyl bromide has also been shown to selectively inhibit the activity of NS5B polymerase, an enzyme that is important in the replication of the hepatitis C virus. The synthetic nature of this molecule makes it an attractive target for analytical methods such as nuclear magnetic resonance spectroscopy. This molecule also shows significant cytotoxicity against cancer cell lines in vitro, as well as inducing tumor necrosis factor-alpha (TNF-α) production in lps-stimulated murine macrophages., Electric Literature of 823-78-9

A variety of minor organobromine compounds are found in nature, but none are biosynthesized or required by mammals. 823-78-9, formula is C7H6Br2, Name is 1-Bromo-3-(bromomethyl)benzene. Organobromine compounds have fallen under increased scrutiny for their environmental impact., Electric Literature of 823-78-9.

Zhou, Yu;Fu, Yan;Yin, Wanchao;Li, Jian;Wang, Wei;Bai, Fang;Xu, Shengtao;Gong, Qi;Peng, Tao;Hong, Yu;Zhang, Dong;Zhang, Dan;Liu, Qiufeng;Xu, Yechun;Xu, H. Eric;Zhang, Haiyan;Jiang, Hualiang;Liu, Hong research published 《 Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate》, the research content is summarized as follows. The acetylcholinesterase (AChE) inhibitors remain key therapeutic drugs for the treatment of Alzheimer’s disease (AD). However, the low-safety window limits their maximum therapeutic benefits. Here, a novel kinetics-driven drug design strategy was employed to discover new-generation AChE inhibitors that possess a longer drug-target residence time and exhibit a larger safety window. After detailed investigations, compound 12 was identified as a highly potent, highly selective, orally bioavailable, and brain preferentially distributed AChE inhibitor. Moreover, it significantly ameliorated cognitive impairments in different mouse models with a lower ED than donepezil. The X-ray structure of the cocrystal complex provided a precise binding mode between 12 and AChE. Besides, the data from the phase I trials demonstrated that 12 had good safety, tolerance, and pharmacokinetic profiles at all preset doses in healthy volunteers, providing a solid basis for its further investigation in phase II trials for the treatment of AD.

823-78-9, 3-Bromobenzyl bromide undergoes reduction with diethylzinc in the presence of Pd(PPh3)4 to yield corresponding hydrocarbon.

3-Bromobenzyl bromide is a useful research compound. Its molecular formula is C7H6Br2 and its molecular weight is 249.93 g/mol. The purity is usually 95%.

3-Bromobenzyl bromide is a molecule that has been synthesized and shown to have anticancer activity. It inhibits the activity of cancer cells by binding to amines in these cells and preventing the formation of hydrogen bonds between these molecules. 3-Bromobenzyl bromide has also been shown to selectively inhibit the activity of NS5B polymerase, an enzyme that is important in the replication of the hepatitis C virus. The synthetic nature of this molecule makes it an attractive target for analytical methods such as nuclear magnetic resonance spectroscopy. This molecule also shows significant cytotoxicity against cancer cell lines in vitro, as well as inducing tumor necrosis factor-alpha (TNF-α) production in lps-stimulated murine macrophages., Electric Literature of 823-78-9

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary